Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 2
2006 1
2007 5
2008 1
2009 5
2010 11
2011 9
2012 7
2013 4
2014 1
2015 4
2016 14
2017 16
2018 19
2019 19
2020 15
2021 21
2022 11
2023 14
2024 9
2025 16
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Sanyal AJ, Newsome PN, Kliers I, Østergaard LH, Long MT, Kjær MS, Cali AMG, Bugianesi E, Rinella ME, Roden M, Ratziu V; ESSENCE Study Group. Sanyal AJ, et al. N Engl J Med. 2025 Jun 5;392(21):2089-2099. doi: 10.1056/NEJMoa2413258. Epub 2025 Apr 30. N Engl J Med. 2025. PMID: 40305708 Clinical Trial.
Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Triantafyllou K, Gkolfakis P, Gralnek IM, Oakland K, Manes G, Radaelli F, Awadie H, Camus Duboc M, Christodoulou D, Fedorov E, Guy RJ, Hollenbach M, Ibrahim M, Neeman Z, Regge D, Rodriguez de Santiago E, Tham TC, Thelin-Schmidt P, van Hooft JE. Triantafyllou K, et al. Among authors: christodoulou d. Endoscopy. 2021 Aug;53(8):850-868. doi: 10.1055/a-1496-8969. Epub 2021 Jun 1. Endoscopy. 2021. PMID: 34062566 Free article.
A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates.
Viazis N, Argyriou K, Kotzampassi K, Christodoulou DK, Apostolopoulos P, Georgopoulos SD, Liatsos C, Giouleme O, Koustenis K, Veretanos C, Stogiannou D, Moutzoukis M, Poutakidis C, Mylonas II, Tseti I, Mantzaris GJ. Viazis N, et al. Among authors: christodoulou dk. Nutrients. 2022 Feb 1;14(3):632. doi: 10.3390/nu14030632. Nutrients. 2022. PMID: 35276991 Free PMC article. Clinical Trial.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Lipidomics in non-alcoholic fatty liver disease.
Kartsoli S, Kostara CE, Tsimihodimos V, Bairaktari ET, Christodoulou DK. Kartsoli S, et al. Among authors: christodoulou dk. World J Hepatol. 2020 Aug 27;12(8):436-450. doi: 10.4254/wjh.v12.i8.436. World J Hepatol. 2020. PMID: 32952872 Free PMC article. Review.
Cystic lesions of the pancreas.
Karoumpalis I, Christodoulou DK. Karoumpalis I, et al. Among authors: christodoulou dk. Ann Gastroenterol. 2016 Apr-Jun;29(2):155-61. doi: 10.20524/aog.2016.0007. Ann Gastroenterol. 2016. PMID: 27065727 Free PMC article. Review.
Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission.
Viazis N, Karamanakos A, Mousourakis K, Christidou A, Fousekis F, Mpakogiannis K, Koukoudis A, Katsanos K, Christodoulou D, Cheila M, Tzouvala M, Zacharopoulou E, Palatianou M, Giouleme O, Katsoula A, Liatsos C, Kyriakos N, Zampeli E, Papathanasiou E, Theodoropoulou A, Karmiris K, Psaroudakis I, Tribonias G, Gazi S, Mole E, Dimitroulas T, Koutsianas C, Vassilopoulos D, Fragoulis GE, Michalakeas N, Papagoras C, Panagakis P, Papoutsaki M, Chasapi V, Stratigos A, Katsikas G. Viazis N, et al. Among authors: christodoulou d. Front Med (Lausanne). 2025 May 16;12:1583401. doi: 10.3389/fmed.2025.1583401. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40454138 Free PMC article.
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D.
Papatheodoridi M, Sevastianos V, Zachou K, Christodoulou D, Koskinas J, Deutsch M, Alexopoulou A, Elefsiniotis I, Triantos C, Gigi E, Androutsakos T, Karagiannakis D, Mani I, Dimitroulopoulos D, Mela M, Sinakos E, Michopoulos S, Mimidis K, Papadopoulos N, Kontos A, Veretanos C, Lymperopoulos D, Giannoulis G, Papadimitropoulos V, Avramopoulou E, Papatheodoridi A, Pantzios S, Vasilieva L, Kranidioti H, Koullias E, Psychos N, Fytili P, Vlachogiannakos J, Cholongitas E, Manolakopoulos S, Goulis I, Dalekos G, Papatheodoridis G. Papatheodoridi M, et al. Among authors: christodoulou d. Liver Int. 2025 Jul;45(7):e70151. doi: 10.1111/liv.70151. Liver Int. 2025. PMID: 40522200 Free PMC article.
192 results